Welcome to our dedicated page for DOCGO news (Ticker: DCGO), a resource for investors and traders seeking the latest updates and insights on DOCGO stock.
DocGo Inc. (NASDAQ: DCGO) is a provider of technology-enabled mobile health and medical transportation services, and its news flow reflects this focus on out‑of‑facility care. Company press releases highlight developments in its mobile health services, remote patient monitoring, ambulance and medical transport operations, and its 50‑state virtual care network.
Investors following DocGo news can expect regular updates on financial results, including quarterly earnings announcements furnished on Form 8‑K, where the company discusses segment performance for Mobile Health Services and Transportation Services, adjusted gross margin metrics and adjusted EBITDA. These releases often include commentary from management on contract activity, care gap closure volumes, and the evolution of its payer and provider relationships.
DocGo’s news also covers contract wins and program launches, such as care gap closure programs with insurance providers, population health initiatives with public health plans and tribal and state health departments, vaccination programs with counties, and multi‑year ambulance contracts with academic medical systems and municipalities. Announcements describing longitudinal care services and transitions of care programs illustrate how the company uses mobile clinicians and telehealth to engage patients at home.
Another recurring theme in DocGo news is strategic activity and capital allocation. The company has issued releases and filed 8‑Ks regarding the acquisition of virtual care platform SteadyMD, as well as updates on its share repurchase program. In addition, DocGo frequently announces participation in healthcare and growth investor conferences, providing insight into how management presents its strategy to the market.
For anyone tracking DCGO, this news page aggregates these earnings releases, contract announcements, program launches, acquisition updates and conference appearances in one place, offering a consolidated view of the company’s operational and strategic milestones over time.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
DocGo (NASDAQ:DCGO) has announced a new multi-year preferred provider agreement with Fresenius Medical Care, the largest kidney dialysis treatment provider in the U.S. The collaboration, effective May 1, 2023, enhances DocGo's offerings in remote patient monitoring, chronic care management, and urgent care services. This partnership builds on a relationship established in 2019, allowing nephrologists to better manage the health of approximately 780,000 end-stage renal disease patients and millions of chronic kidney disease patients in the U.S. DocGo aims to deliver proactive health care, reducing hospitalization risks and improving patient outcomes through advanced technology and integration with Fresenius Medical Care's resources.
DocGo, a leading provider of last-mile mobile health services, will announce its first-quarter financial results for the period ending March 31, 2023, after markets close on May 8, 2023. A conference call for investors and analysts is scheduled for 5:00 PM EDT on the same day.
The company aims to disrupt traditional healthcare delivery by providing affordable and quality care to patients directly at home or work, leveraging innovative technology and certified health professionals. Their services include telehealth and integrated medical transport, aiming to enhance patient care while improving operational efficiencies for healthcare providers.
DocGo Inc (NASDAQ: DCGO) announced the participation of President and COO Lee Bienstock in a fireside chat at the 22nd Annual Needham Virtual Healthcare Conference on April 20 at 2:15 PM ET. The event aims to showcase the company's innovative approach in providing last-mile mobile health services, enhancing patient care through technology and certified health professionals. DocGo's services aim to improve healthcare delivery by bridging physical and virtual care, empowering telehealth capabilities in patients' homes or workplaces. A webcast will be accessible on DocGo's investor relations website.
DocGo (NASDAQ: DCGO) announced that CEO Anthony Capone will join a panel at HIMSS23 in Chicago on April 18, from 3:00 PM to 4:00 PM. The panel, led by Life365’s Kent Dicks, will discuss the "Virtual First Approach to Augment Consumer Care Delivery at Home." Capone aims to explore virtual care technology solutions to enhance patient engagement and outcomes. This event highlights the growing importance of virtual care in healthcare delivery. For more details, please register for HIMSS23 here.
DocGo (Nasdaq:DCGO) reported substantial growth in new business contracts, securing over $180 million in revenue contracts and expansions for the next three years since January 2023. Key partnerships include a not-for-profit health system in Philadelphia, a hospital network in Long Island, and federally funded hospitals. The company plans to enhance its mobile health services and will hire hundreds of clinicians while expanding its fleet by 100 vehicles, promoting sustainable practices through its Zero Emission initiative. All contracts are expected to roll out by the end of Q3 2023.
DocGo Inc. (Nasdaq: DCGO) reported a significant revenue increase in 2022, reaching $440.5 million, a 38% rise from $318.7 million in 2021. Mobile Health revenue grew to $325.9 million, marking a 39% increase, while net income rose by 60% to $30.7 million. The company projects 2023 revenue between $500-$510 million, a 14%-16% growth over 2022. In Q4 2022, total revenue was $108.8 million, down from $121.3 million in Q4 2021, impacted by reduced COVID testing revenue. DocGo announced new partnerships and secured a $90 million line of credit, emphasizing continued growth in mobile health services.